Clinical trial

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

NCT00529048

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Oral Glucose Tolerance Test Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Isoglycemic clamp Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Gastric emptying rate Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-10-01

PhaseN/A

Conditions

Incretin Effectunresolved

Interventions

Oral Glucose Tolerance TestOTHER

Isoglycemic clampOTHER

Gastric emptying rateOTHER

Sponsors & collaborators

Herlev Hospitallead sponsor

University of Copenhagencollaborator

Merck Sharp & Dohme LLCcollaborator

Forskningsrådetcollaborator

Diabetesforeningencollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00529048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.